NCT04807998

Brief Summary

It is known that some factors are associated with emergence agitation(EA), and investigators are still unable to predict accurately those who undergoing maxillofacial surgery are at great risks.This study intend to identify the risk factors for EA and to explore the mechanism of EA , which is helpful for early prediction, prevention and treatment in children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 19, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

November 19, 2021

Status Verified

November 1, 2021

Enrollment Period

1.2 years

First QC Date

February 21, 2021

Last Update Submit

November 12, 2021

Conditions

Keywords

pediatric emergence agitationpostoperative Painmetabolomics

Outcome Measures

Primary Outcomes (2)

  • Risk factors for pain and emergence agitation following maxillofacial surgery in children

    Children aged 3-12 years who undergoing palatopharyngoplasty/adenoidectomy or adenotonsillectomy, auricle reconstruction, and photodynamic therapy for vascular malformations were enrolled in this study. The general information of children, preoperative anxiety state, preoperative anxiety state of parents, operation type, anesthesia method, analgesic drug, postoperative pain and emergence agitation degree were collected. Multivariate regression analysis were conducted to identify the risk factors for pain and emergence agitation following maxillofacial surgery in children.

    within 48 hours

  • The levels of serum and urine metabolites in EA

    Children who underwent adenoidectomy or adenotonsillectomy in part I of this study were included. Urine (5ml) and peripheral venous blood (1ml) samples were collected before anesthesia and immediately after completion of agitation score. EA was defined as a Pediatric anesthesia emergence delirium(PAED) score ≥12 points. Children in EA group were matched with non-EA group, and UPLC-Q TOF/MS analysis was performed to identify the metabolites between two groups during the recovery period.

    within 24 hours

Study Arms (2)

Group EA

Serum and Urine samples were collected before anesthesia and immediately after surgery from children who enrolled in part I and undergoing the adenoidectomy or adenotonsillectomy. A PAED score of 12 or greater was defined as EA. The serum and urine samples were analyzed by UHPLC-Q-TOF/MS separately.

Group non-EA

Serum and Urine samples were collected before anesthesia and immediately after surgery from children who enrolled in part I and undergoing the adenoidectomy or adenotonsillectomy. A PAED score less than 12 was defined as non-EA. The serum and urine samples were analyzed by UHPLC-Q-TOF/MS separately.

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Patients undergoing palatopharyngoplasty/tonsillar and/or adenoidectomy, auricle reconstruction, and photodynamic therapy for vascular malformations on face.

You may qualify if:

  • Patients undergoing palatopharyngoplasty/tonsillar and/or adenoidectomy, auricle reconstruction, and photodynamic therapy for vascular malformations on face.
  • Aged between 3 years and 12 years.
  • American Society of Anesthesiologists(ASA) class I-II.

You may not qualify if:

  • Patients with developmental delays.
  • Patients with mental disorders.
  • Patients with severe liver and kidney damage,or other heart and lung disease.
  • Reject to participate in the trials.
  • Eligibility Criteria in Part II
  • Patients who underwent adenoidectomy or adenotonsillectomy in part I of this study.
  • Aged between 3 years and 7 years.
  • American Society of Anesthesiologists(ASA) class I-II.
  • Patients who underwent sevoflurane anesthesia maintainance.
  • Patients with developmental delays or mental disorders.
  • Patients with neurological or psychiatric diseases.
  • Patients with severe liver and kidney damage,or other heart and lung disease.
  • Patients with metabolic diseases or family inherited diseases.
  • Patients who received drug treatment or intravenous nutritional supports.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai No.9 People's Hospital

Shanghai, China

Location

Related Publications (1)

  • Li Y, Li J, Shi Y, Zhou X, Feng W, Han L, Ma D, Jiang H, Yuan Y. Urinary Aromatic Amino Acid Metabolites Associated With Postoperative Emergence Agitation in Paediatric Patients After General Anaesthesia: Urine Metabolomics Study. Front Pharmacol. 2022 Jul 19;13:932776. doi: 10.3389/fphar.2022.932776. eCollection 2022.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Patients' blood and urine

MeSH Terms

Conditions

Emergence DeliriumPainPain, Postoperative

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Jingjie Li, M.D

    Shanghai No.9 People's Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-director

Study Record Dates

First Submitted

February 21, 2021

First Posted

March 19, 2021

Study Start

September 28, 2020

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

November 19, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations